Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parameter estimation in longitudinal studies with outcome-dependent follow-up.

Stuart R Lipsitz1, Garrett M Fitzmaurice, Joseph G Ibrahim

  • 1Department of Biometry and Epidemiology, Medical University of South Carolina, Charleston 29425, USA. lipsitzs@musc.edu

Biometrics
|September 17, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?"

European journal of cancer (Oxford, England : 1990)·2026
Same author

A novel maternal prenatal risk index to predict mortality-weighted severe maternal morbidity at hospitalization: a retrospective cohort study.

Lancet regional health. Americas·2026
Same author

Information-Based Composite Likelihood Method for Hybrid Meta-Analysis Integrating Individual Participant Data and Aggregated Data.

Statistics in medicine·2026
Same author

Circulating miRNA-Protein Signatures Predict Outcomes in Pediatric Dilated Cardiomyopathy.

bioRxiv : the preprint server for biology·2026
Same author

Canopy2: Tumor Phylogeny Inference by Bulk DNA and Single-Cell RNA Sequencing.

Statistics in biosciences·2026
Same author

Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials.

The Lancet. Oncology·2025

This study addresses regression parameter estimation in longitudinal data analysis where follow-up times depend on patient health. Accurate covariance modeling is crucial to avoid biased estimates in these complex observational studies.

Area of Science:

  • Biostatistics
  • Longitudinal Data Analysis
  • Statistical Modeling

Background:

  • Observational studies often involve repeated measurements over time.
  • Follow-up times may be irregular and influenced by previous health outcomes.
  • This presents challenges for standard statistical modeling approaches.

Purpose of the Study:

  • To investigate regression parameter estimation in longitudinal data models.
  • To examine scenarios where follow-up times are not fixed but depend on prior outcomes.
  • To assess the impact of covariance model misspecification on parameter estimates.

Main Methods:

  • Focus on general linear models for longitudinal data with multivariate Gaussian distributions.
  • Explored assumptions for likelihood function separation into outcome and follow-up time processes.

Related Experiment Videos

  • Utilized maximum likelihood (ML) estimation, noting standard software applicability.
  • Investigated bias resulting from misspecification of the covariance model.

    • Main Results:

    • Likelihood function separation allows ignoring follow-up time process for ML estimation of regression parameters.
    • Misspecification of the covariance model can lead to biased regression parameter estimates.
    • Simulation studies indicate potential for considerable bias due to covariance misspecification.

    Conclusions:

    • Maximum likelihood estimation of regression parameters is feasible without modeling follow-up times, provided specific assumptions hold.
    • Careful specification of the covariance structure for repeated measures is essential to prevent biased results.
    • Findings are illustrated with a study on childhood leukemia treatment cardiotoxicity.